Migraine: open trials in United Kingdom

9 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Trial Treatment · Phase 3 · Pfizer
Leicester Royal Infirmary, Leicester · Great Ormond Street Hospital For Children NHS Foundation Trust, London · Re:Cognition Health Limited, London
Registry updated 2026-10-27
NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
NHS Lothian - Royal Hospital for Children & Young People (RHCYP), Edinburgh · Royal Devon and Exeter Hospital NHS Trust - PPDS, Exeter · NHS Greater Glasgow and Clyde-Glasgow Clinical Research Facility - Queen Elizabeth University Hos..., Glasgow · James Paget University Hospitals NHS Foundation Trust, Great Yarmouth · Great Ormond Street Hospital For Children NHS Foundation Trust, London
Registry updated 2026-10-16
NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
NHS Lothian - Royal Hospital for Children & Young People (RHCYP), Edinburgh · NHS Greater Glasgow and Clyde-Glasgow Clinical Research Facility - Queen Elizabeth University Hos..., Glasgow · James Paget University Hospitals NHS Foundation Trust, Great Yarmouth · Great Ormond Street Hospital For Children NHS Foundation Trust, London
Registry updated 2026-10-14
NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
NHS Lothian - Royal Hospital for Children & Young People (RHCYP), Edinburgh · NHS Greater Glasgow and Clyde (NHSGGC) - Royal Hospital for Children - Glasgow (Royal Hospital fo..., Glasgow · James Paget University Hospitals NHS Foundation Trust, Great Yarmouth · Great Ormond Street Hospital For Children NHS Foundation Trust, London
Registry updated 2026-10-14
NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Trial Treatment · Phase 3 · AbbVie
Royal Aberdeen Children's Hospital /ID# 271664, Aberdeen · Medway Maritime Hospital /ID# 271885, Gillingham · Leeds Teaching Hospitals NHS Trust /ID# 273449, Leeds · Great Ormond Street Children's Hospital /ID# 271550, London · Stepping Hill Hospital-Stockport NHS foundation trust /ID# 271883, Stockport
Registry updated 2026-10-09
NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Trial Treatment · Phase 3 · AbbVie
NHS Grampian /ID# 249067, Aberdeen · Medway NHS Foundation Trust /ID# 249065, Gillingham · Great Ormond Street Children's Hospital /ID# 262933, London · Stepping Hill Hospital-Stockport NHS foundation trust /ID# 261121, Stockport
Registry updated 2026-10-06
NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Trial Treatment · Phase 3 · Pfizer
West Walk Surgery, Bristol · The Walton Centre NHS Foundation Trust, Fazakerley · Panthera Biopartners - Glasgow, Glasgow · Hull University Teaching Hospitals NHS Trust, Hull · Re:Cognition Health - London, London · Bioluminux, Milton Keynes · Panthera Biopartners - Sheffield, Sheffield · Panthera Clinic - York, York
Registry updated 2026-07-09
NCT05707949
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Trial Treatment · Phase 3 · AbbVie
NHS Grampian /ID# 251474, Aberdeen · Stockport NHS foundation trust /ID# 261562, Stockport
Registry updated 2025-08-11
NCT06716944
Self-acupuncture for Migraines Feasibility Study
Trial Treatment · Phase 1/2 · University of West London
Royal London Hospital for Integrated Medicine, London
Registry updated 2024-12-04

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error